Cleared Traditional

K233445 - Bactiseal Catheters (FDA 510(k) Clearance)

Also includes:
Bactiseal Barium Striped Catheters Bactiseal Endoscopic Ventricular Catheter
Jan 2024
Decision
90d
Days
Class 2
Risk

K233445 is an FDA 510(k) clearance for the Bactiseal Catheters. This device is classified as a Shunt, Central Nervous System And Components (Class II - Special Controls, product code JXG).

Submitted by Integra Lifesciences Production Corporation (Mansfield, US). The FDA issued a Cleared decision on January 17, 2024, 90 days after receiving the submission on October 19, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5550.

Submission Details

510(k) Number K233445 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 2023
Decision Date January 17, 2024
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code JXG - Shunt, Central Nervous System And Components
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5550